Megan (Suhoski) Davis
Megan (Suhoski) Davis
Potvrđena adresa e-pošte na
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
C Carpenito, MC Milone, R Hassan, JC Simonet, M Lakhal, MM Suhoski, ...
Proceedings of the National Academy of Sciences 106 (9), 3360-3365, 2009
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
A Varela-Rohena, PE Molloy, SM Dunn, Y Li, MM Suhoski, RG Carroll, ...
Nature medicine 14 (12), 1390-1395, 2008
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
MM Suhoski, TN Golovina, NA Aqui, VC Tai, A Varela-Rohena, ...
Molecular Therapy 15 (5), 981-988, 2007
The inducible costimulator (ICOS) is critical for the development of human TH17 cells
CM Paulos, C Carpenito, G Plesa, MM Suhoski, A Varela-Rohena, ...
Science translational medicine 2 (55), 55ra78-55ra78, 2010
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy
H Zhang, KM Snyder, MM Suhoski, MV Maus, V Kapoor, CH June, ...
The Journal of Immunology 179 (7), 4910-4918, 2007
CD28 costimulation is essential for human T regulatory expansion and function
TN Golovina, T Mikheeva, MM Suhoski, NA Aqui, VC Tai, X Shan, R Liu, ...
The Journal of Immunology 181 (4), 2855-2868, 2008
Artificial antigen presenting cells and uses therefor
JL Riley, CH June, RH Vonderheide, N Aqui, MM Suhoski
US Patent 7,754,482, 2010
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen …
KL Hippen, P Harker-Murray, SB Porter, SC Merkel, A Londer, DK Taylor, ...
Blood, The Journal of the American Society of Hematology 112 (7), 2847-2857, 2008
Cdc42-interacting protein–4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse
PP Banerjee, R Pandey, R Zheng, MM Suhoski, L Monaco-Shawver, ...
The Journal of experimental medicine 204 (10), 2305-2320, 2007
Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients
KT Marcucci, JK Jadlowsky, WT Hwang, M Suhoski-Davis, VE Gonzalez, ...
Molecular therapy 26 (1), 269-279, 2018
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells
SJAM Santegoets, AW Turksma, MM Suhoski, AGM Stam, SM Albelda, ...
Journal of translational medicine 11 (1), 1-10, 2013
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
IS Junttila, RJ Creusot, I Moraga, DL Bates, MT Wong, MN Alonso, ...
Nature chemical biology 8 (12), 990-998, 2012
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
Q Ye, M Loisiou, BL Levine, MM Suhoski, JL Riley, CH June, G Coukos, ...
Journal of translational medicine 9 (1), 1-13, 2011
TH1, TH2, and TH17 cells instruct monocytes to differentiate into specialized dendritic cell subsets
MN Alonso, MT Wong, AL Zhang, D Winer, MM Suhoski, LL Tolentino, ...
Blood, The Journal of the American Society of Hematology 118 (12), 3311-3320, 2011
Artificial antigen presenting cells and uses thereof
JL Riley, CH June, RH Vonderheide, N Aqui, MM Davis
US Patent 9,555,105, 2017
Nonviral RNA chimeric antigen receptor–modified T cells in patients with Hodgkin lymphoma
J Svoboda, SR Rheingold, SI Gill, SA Grupp, SF Lacey, I Kulikovskaya, ...
Blood, The Journal of the American Society of Hematology 132 (10), 1022-1026, 2018
Adoptive immunotherapy: good habits instilled at youth have long-term benefits
CM Paulos, MM Suhoski, G Plesa, T Jiang, S Basu, TN Golovina, S Jiang, ...
Immunologic research 42, 182-196, 2008
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
I Moraga, D Richter, S Wilmes, H Winkelmann, K Jude, C Thomas, ...
Science signaling 8 (402), ra114-ra114, 2015
Artificial antigen presenting cells and uses therefor
JL Riley, CH June, RH Vonderheide, N Aqui, MM Suhoski
US Patent 8,722,400, 2014
Pilot study of anti-CD19 chimeric antigen receptor T cells (CTL019) in conjunction with salvage autologous stem cell transplantation for advanced multiple myeloma
AL Garfall, EA Stadtmauer, MV Maus, WT Hwang, DT Vogl, AD Cohen, ...
Blood 128 (22), 974, 2016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20